Skip to main content
SpringerLink
Log in

Biology of tree pollen allergens

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

More than 25% of the population suffer from type I allergy. Pollens from trees of the Fagales, Oleaceae, and Cupressaceae belong to the most potent and frequent allergen sources. During the past 15 years, the nature of the most important allergens has been identified by molecular biological techniques, and recombinant allergens equivalent to the natural allergens have been produced. These advances provide insight into the biological functions of important allergens and allow the development of novel forms of diagnosis and therapy. In this review, we focus on Fagales allergens to illustrate the impact of recombinant allergens on diagnosis and therapy. We discuss structural similarities as a molecular basis for crossreactivities and develop diagnostic concepts by using speciesspecific marker allergens as well as highly cross-reactive allergens. The identification of the allergen recognition profiles of patients with recombinant allergens allows a more precise selection of patients for available forms of allergy treatment. Moreover, we describe novel recombinant allergen-based forms of specific immunotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. D’Amato G, Bonini S (eds): Pollenosis 2000: Global Approach.Naples, Italy: JGC Editions; 2001.

    Google Scholar 

  2. Kulig M, Klettke U, Wahn V, et al.: Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol 2000, 106:832–839.

    Article  PubMed  CAS  Google Scholar 

  3. Niederberger V, Niggemann B, Kraft D, et al.: Evolution of IgM, IgE and IgG(1-4) antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanisms. Eur J Immunol 2002, 32:576–584.

    Article  PubMed  CAS  Google Scholar 

  4. Mittermann I, Swoboda I, Pierson E, et al.: Molecular cloning and characterization of profilin from tobacco (Nicotina tabacum): increased profilin expression during pollen maturation. Plant Mol Biol 1995, 27:137–146.

    Article  PubMed  CAS  Google Scholar 

  5. Ahlholm JU, Helander ML, Savolainen J: Genetic and environmental factors affecting the allergenicity of birch (Betula pubescens ssp. Czerepanovii [Orl.] Hamet-ahti) pollen. Clin Exp Allergy 1998, 28:1384–1388.

    Article  PubMed  CAS  Google Scholar 

  6. Kondo Y, Ipsen H, Lowenstein H, et al.: Comparison of concentrations of Cry j 1 and Cry j 2 in diploid and triploid Japanese cedar (Cryptomeria japonica) pollen extracts. Allergy 1997, 52:455–459.

    Article  PubMed  CAS  Google Scholar 

  7. Helander ML, Savolainen J, Ahlholm J: Effects of air pollution and other environmental factors on birch pollen allergens. Allergy 1997, 52:1207–1214.

    Article  PubMed  CAS  Google Scholar 

  8. Tashpulatov AS, Clement P, Akimcheva SA, et al.: A model system to study the environment-dependent expression of the Bet v 1a gene encoding the major birch pollen allergen. Int Arch Allergy Immunol 2004, 134:1–9.

    Article  PubMed  CAS  Google Scholar 

  9. Grote M, Vrtala S, Valenta R: Monitoring of two allergens, Bet v 1 and profilin, in dry and rehydrated birch pollen by immunogold electron microscopy and immunoblotting. J Histochem Cytochem 1993, 41:745–750.

    PubMed  CAS  Google Scholar 

  10. Grote M, Valenta R, Reichelt R: Abortive pollen germination: a mechanism of allergen release in birch, alder, and hazel revealed by immunogold electron microscopy. J Allergy Clin Immunol 2003, 111:1017–1023.

    Article  PubMed  Google Scholar 

  11. Diaz-Sanchez D, Tsien A, Fleming J, Saxon A: Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2 type pattern. J Immunol 1997, 158:2406–2413.

    PubMed  CAS  Google Scholar 

  12. Knox RB, Suphioglu C, Taylor P, et al.: Major grass pollen allergen Lol p 1 binds to diesel exhaust particles: implications for asthma and air pollution. Clin Exp Allergy 1997, 27:246–251.

    Article  PubMed  CAS  Google Scholar 

  13. Traidl-Hoffmann C, Kasche A, Menzel A, et al.: Impact of pollen on human health: more than allergen carriers? Int Arch Allergy Immunol 2003, 131:1–13.

    Article  PubMed  Google Scholar 

  14. Mothes N, Westritschnig K, Valenta R: Tree pollen allergens. In Allergens and Allergen Immunotherapy for Allergic Diseases, edn 3. Edited by Lockey RF, Bukantz SC, Bousquet J. New York: Marcel Dekker; 2004:165–184.

    Google Scholar 

  15. Rodriguez R, Villalba M, Monsalve RI, Batanero E: The spectrum of olive pollen allergens. Int Arch Allergy Immunol 2001, 125:185–195.

    Article  PubMed  CAS  Google Scholar 

  16. Schwietz LA, Goetz DW, Whisman BA, Reid MJ: Crossreactivity among conifer pollens. Ann Allergy Asthma Immunol 2000, 84:87–93.

    Article  PubMed  CAS  Google Scholar 

  17. Wide L, Bennich H, Johnsson SG: Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet 1967, 2:1105–1107.

    Article  PubMed  CAS  Google Scholar 

  18. Vik H, Florvaag E, Apold J, et al.: Comparative studies on tree pollen allergens. IV. Evaluation of two commercially available allergen extracts of alder (Alnus incana) and birch (Betula verrucosa) pollen. Int Arch Allergy Appl Immunol 1982, 68:371–376.

    PubMed  CAS  Google Scholar 

  19. Eriksson NE, Wihl JA, Arrendal H, Strandhede SO: Tree pollen allergy. III. Cross reactions based on results from skin prick tests and the RAST in hay fever patients: a multi-centre study. Allergy 1987, 42:205–214.

    Article  PubMed  CAS  Google Scholar 

  20. Yman L: Botanical Relations and Immunological Cross-reactions in Pollen Allergy. Uppsala, Sweden: Pharmacia Diagnostics AB; 1978.

    Google Scholar 

  21. Moller C, Dreborg S: Cross-reactivity between deciduous trees during immunotherapy. I. In vivo results. Clin Allergy 1986, 16:135–143.

    Article  PubMed  CAS  Google Scholar 

  22. Hemmens VJ, Baldo BA, Elsayed S, Bass D: Allergic response to birch and alder pollen allergens influenced by geographical location of allergic subjects. Int Arch Allergy Appl Immunol 1988, 87:321–328.

    PubMed  CAS  Google Scholar 

  23. Petersen BN, Janniche H, Munch EP, et al.: Immunotherapy with partially purified and standardized tree pollen extracts. I. Clinical results from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel. Allergy 1988, 43:353–362.

    Article  PubMed  CAS  Google Scholar 

  24. Wihl JA, Ipsen H, Petersen BN, et al.: Immunotherapy with partially purified and standardized tree pollen extracts. II. Results of skin prick tests and nasal provocation tests from a three-year double-blind study of patients treated with pollen extracts either of birch or combinations of alder, birch and hazel. Allergy 1988, 43:363–369.

    Article  PubMed  CAS  Google Scholar 

  25. Ipsen H, Schwartz B, Wihl JA, et al.: Immunotherapy with partially purified and standardized tree pollen extracts. III. Specific IgE response to the major allergens of alder, birch and hazel pollen during immunotherapy. Allergy 1988, 43:370–377.

    Article  PubMed  CAS  Google Scholar 

  26. D’Amato G, Mullins J, Nolard N, et al.: City spore concentrations in the European Economic Community (EEC). VII. Oleaceae (Fraxinus, Ligustrum, Olea). Clin Allergy 1988, 18:541–547.

    Article  PubMed  CAS  Google Scholar 

  27. Yoo TJ, Spitz E, McGerity JL: Conifer pollen allergy: studies of immunogenicity and cross antigenicity of conifer pollens in rabbit and man. Ann Allergy 1975, 34:87–93.

    PubMed  CAS  Google Scholar 

  28. Valenta R, Kraft D: Recombinant allergen molecules: tools to study effector cell activation. Immunol Rev 2001, 179:119–127.

    Article  PubMed  CAS  Google Scholar 

  29. Valenta R, Kraft D: From allergen structure to new forms of allergen-specific immunotherapy. Curr Opin Immunol 2002, 14:718–727.

    Article  PubMed  CAS  Google Scholar 

  30. Di Felice G, Barletta B, Tinghino R, Pini C: Cupressaceae pollinosis: identification, purification and cloning of relevant allergens. Int Arch Allergy Immunol 2001, 125:129.

    Article  Google Scholar 

  31. Mothes N, Horak F, Valenta R: The transition from a botanical to a molecular classification in tree pollen allergy: Implications for diagnosis and therapy. Int Arch Allergy Immunol 2004, In press.

  32. Breiteneder H, Pettenburger K, Bito A, et al.: The gene coding for the major birch pollen allergen, Bet v 1, is highly homologous to a pea disease resistance response gene. EMBO J 1989, 8:1935–1938.

    PubMed  CAS  Google Scholar 

  33. Hoffmann-Sommergruber K: Plant allergens and pathogenesisrelated proteins: What do they have in common? Int Arch Allergy Immunol 2000, 122:155–166.

    Article  PubMed  CAS  Google Scholar 

  34. Bufe A, Spangfort MD, Kahlert H, et al.: The major birch pollen allergen, Bet v 1, shows ribonuclease activity. Planta 1996, 199:413–415.

    Article  PubMed  CAS  Google Scholar 

  35. Markovic-Housley Z, Degano M, Lamba D, et al.: Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its likely biological function as a plant steroid carrier. J Mol Biol 2003, 325:123–133.

    Article  PubMed  CAS  Google Scholar 

  36. Mogensen JE, Wimmer R, Larsen JN, et al.: The major birch allergen, Bet v 1, shows affinity for a broad spectrum of physiological ligands. J Biol Chem 2002, 277:23684–23592.

    Article  PubMed  CAS  Google Scholar 

  37. Elbaz M, Bremer J, Thibout E, et al.: A periwinkle PR-10 protein, CrPR-10a, has insecticide activity. Planta 2004, In press.

  38. Valenta R, Duchene M, Vrtala S, et al.: Recombinant allergens for immunoblot diagnosis of tree pollen allergy. J Allergy Clin Immunol 1991, 88:889–894.

    Article  PubMed  CAS  Google Scholar 

  39. Menz G, Dolecek C, Schonheit-Kenn U, et al.: Serological and skin test diagnosis of birch pollen allergy with recombinant Bet v 1, the major birch pollen allergen. Clin Exp Allergy 1996, 26:50–60.

    Article  PubMed  CAS  Google Scholar 

  40. Niederberger V, Pauli G, Gronlund H, et al.: Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel and oak pollen: a quantitative IgE inhibition study with sera from different populations. J Allergy Clin Immunol 1998, 102:579–591.

    Article  PubMed  CAS  Google Scholar 

  41. Valenta R, Breiteneder H, Pettenburger, et al.: Homology of the major birch-pollen allergen, Bet v 1, with the major pollen allergens of alder, hazel, and hornbeam at the nucleic acid level as determined by cross-hybridization. J Allergy Clin Immunol 1991, 87:977–982.

    Article  Google Scholar 

  42. Breiteneder H, Ferreira F, Reikerstorfer A, et al.: cDNA cloning and expression in Escherichia coli of Aln g I, the major allergen in pollen of alder (Alnus glutinosa). J Allergy Clin Immunol 1992, 90:909–917.

    Article  PubMed  CAS  Google Scholar 

  43. Larsen JN, Stroman P, Ipsen H: PCR based cloning and sequencing of isogenes encoding the tree pollen major allergen Car b I from Carpinus betulus, hornbeam. Mol Immunol 1992, 29:703–711.

    Article  PubMed  CAS  Google Scholar 

  44. Vanek-Krebitz M, Hoffmann-Sommergruber K, Laimer da Camara Machado M, et al.: Cloning and sequencing of Mal d 1, the major allergen from apple (Malus domestica), and its immunological relationship to Bet v 1, the major birch pollen allergen. Biochem Biophys Res Commun 1995, 214:538–551.

    Article  PubMed  CAS  Google Scholar 

  45. Ebner C, Hirschwehr R, Bauer L, et al.: Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol 1995, 95:962–969.

    Article  PubMed  CAS  Google Scholar 

  46. Jensen-Jarolim E, Leitner A, Hirschwehr R, et al.: Characterization of allergens in Apiaceae spices: anise, fennel, coriander cumin. Clin Exp Allergy 1997, 27:1299–1306.

    Article  PubMed  CAS  Google Scholar 

  47. Hoffmann-Sommergruber K, O’Riordain G, Ahorn H, et al.:Molecular characterization of Dau c 1, the Bet v 1 homologous protein from carrot and its cross-reactivity with Bet v 1 and Api g 1. Clin Exp Allergy 1999, 29:840–847.

    Article  PubMed  CAS  Google Scholar 

  48. Scheurer S, Son DY, Boehm M, et al.: Cross-reactivity and epitope analysis of Pru av 1, the major cherry allergen. Mol Immunol 1999, 36:155–167.

    Article  PubMed  CAS  Google Scholar 

  49. Karamloo F, Scheurer S, Wangorsch A, et al.: Pyr c 1, the major allergen from pear (Pyrus communis), is a new member of the Bet v 1 allergen family. J Chromatogr B Biomed Sci Appl 2001, 756:281–293.

    Article  PubMed  CAS  Google Scholar 

  50. Kazemi-Shirazi L, Pauli G, Purohit A, et al.: Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy. J Allergy Clin Immunol 2000, 105:116–125.

    Article  PubMed  CAS  Google Scholar 

  51. Moverare R, Westritschnig K, Svensson M, et al.: Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization. Int Arch Allergy Immunol 2002, 128:325–335.

    Article  PubMed  CAS  Google Scholar 

  52. Valenta R, Duchene M, Pettenburger K, et al.: Identification of profilin as a novel pollen allergen: IgE autoreactivity in sensitized individuals. Science 1991, 253:557–560.

    Article  PubMed  CAS  Google Scholar 

  53. Valenta R, Ferreira F, Grote M, et al.: Identification of profilin as an actin-binding protein in higher plants. J Biol Chem 1993, 268:22777–22781.

    PubMed  CAS  Google Scholar 

  54. Seiberler S, Scheiner O, Kraft D, et al.: Characterization of a birch pollen allergen, Bet v III, representing a novel class of Ca2+ binding proteins; specific expression in mature pollen and dependence of patients’ IgE binding on protein-bound Ca2+. EMBO J 1994, 13:3481–3486.

    PubMed  CAS  Google Scholar 

  55. Twardosz A, Hayek B, Seiberler S, et al.: Molecular characterization, expression in Escherichia coli and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4. Biochem Biophys Res Commun 1997, 239:197–204.

    Article  PubMed  CAS  Google Scholar 

  56. Engel E, Richter K, Obermeyer G, et al.: Immunological and biological properties of Bet v 4, a novel birch pollen allergen with two EF-hand calcium-binding domains. J Biol Chem 1997, 272:8630–8637.

    Article  Google Scholar 

  57. Valenta R, Hayek B, Seiberler S, et al.: Calcium-binding allergens: from plants to man. Int Arch Allergy Immunol 1998, 117:160–166.

    Article  PubMed  CAS  Google Scholar 

  58. Karamloo F, Wangorsch A, Kasahara H, et al.: Phenylcoumaran benzylic ether and isoflavonoid reductases are a new class of cross-reactive allergens in birch pollen, fruits and vegetables. Eur J Biochem 2001, 268:5310–5320.

    Article  PubMed  CAS  Google Scholar 

  59. Cadot P, Diaz JF, Proost P, et al.: Purification and characterization of an 18-kd allergen of birch (Betula verrucosa) pollen: Identification as a cyclophilin. J Allergy Clin Immunol 2000, 105:286–291.

    Article  PubMed  CAS  Google Scholar 

  60. Mahler V, Fischer S, Heiss S, et al.: cDNA cloning and characterization of a cross-reactive birch pollen allergen: identification as a pectin esterase. Int Arch Allergy Immunol 2001, 124:64–66.

    Article  PubMed  CAS  Google Scholar 

  61. Kazemi-Shirazi L, Niederberger V, Linhart B, et al.: Recombinant marker allergens: Diagnostic gate keepers for therapy of allergy. Int Arch Allergy Immunol 2002, 127:259–268.

    Article  PubMed  CAS  Google Scholar 

  62. Valenta R, Lidholm J, Niederberger V, et al.: The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999, 29:896–904.

    Article  PubMed  CAS  Google Scholar 

  63. Hiller R, Laffer S, Harwanegg C, et al.: Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002, 16:414–416.

    PubMed  CAS  Google Scholar 

  64. Harwanegg C, Laffer S, Hiller R, et al.: Microarrayed recombinant allergens for diagnosis of allergy. Clin Exp Allergy 2003, 33:7–13.

    Article  PubMed  CAS  Google Scholar 

  65. Westritschnig K, Sibanda E, Thomas W, et al.: Analysis of the sensitization profile towards allergens in central Africa. Clin Exp Allergy 2003, 33:22–27. This paper reveals unexpected sensitization profiles in a Central African population of allergic patients.

    Article  PubMed  CAS  Google Scholar 

  66. Ball T, Sperr WR, Valent P, et al.: Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Eur J Immunol 1999, 29:2026–2036.

    Article  PubMed  CAS  Google Scholar 

  67. Mothes N, Heinzkill M, Drachenberg KJ, et al.: Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted IgE production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy 2003, 33:1–11. Using recombinant allergens for monitoring of immunotherapy, the importance of blocking antibodies has been reevaluated.

    Article  Google Scholar 

  68. Moverare R, Elfman L, Vesterinen E, et al.: Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy 2002, 57:423–430. Using recombinant allergens, the authors discover that extract-based immunotherapy can induce de novo IgE sensitization in patients.

    Article  PubMed  CAS  Google Scholar 

  69. van Hage-Hamsten M, Valenta R: Specific immunotherapy: the induction of new IgE-specificities? Allergy 2002, 57:375–358.

    Article  PubMed  Google Scholar 

  70. Valenta R: The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol 2002, 2:446–453. The mechanisms of immunotherapy and future therapy strategies are discussed.

    PubMed  CAS  Google Scholar 

  71. Valenta R, Ball T, Focke M, et al.: Immunotherapy of allergic disease. Adv Immunol 2004, 82:105–153. The mechanisms of immunotherapy and future therapy strategies are discussed.

    Article  PubMed  CAS  Google Scholar 

  72. Westritschnig K, Valenta R: Can we genetically engineer safer and more effective immunotherapy reagents? Curr Opin Allergy Immunol 2003, 3:495–500.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Immunopathology, Department of Pathophysiology, Vienna General Hospital, AKH, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria

    Nadine Mothes MD & Rudolf Valenta MD

Authors
  1. Nadine Mothes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rudolf Valenta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mothes, N., Valenta, R. Biology of tree pollen allergens. Curr Allergy Asthma Rep 4, 384–390 (2004). https://doi.org/10.1007/s11882-004-0089-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-004-0089-y

Keywords

Search

Navigation